<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc. MRNA, -6.37% beat earnings and revenue expectations for the fourth quarter of 2021 after announcing Thursday that its COVID-19 vaccine brought in nearly $7 billion in product sales during the final three months of the year. Moderna had a profit of $4.8 billion, or $11.29 per share, in the fourth quarter of 2021, after reporting a loss of $272 million, or 69 cents per share, in the fourth quarter of 2020.
...read full article on Market Watch
